Peer reviewed journals 1993
175. Kruszynska YT, Meyer-Alber A, Darakhshan F, Home PD, McIntyre N. Metabolic handling of orally administered glucose in cirrhosis. J Clin Invest 1993; 91: 1057-1066.
176. Bardsley MJ, Astell S, McCallum A, Home PD. The performance of three measures of health status in an outpatient diabetes population. Diabetic Med 1993; 10: 619-626.
177. European IDDM Policy Group 1993. Consensus Guidelines for the management of insulin-dependent (Type 1) Diabetes. Diabetic Med 1993; 10: 990-1005.
178. Harris PE, Walker M, Clark F, Home PD, Alberti KGMM. Forearm muscle metabolism in primary hypothyroidism. Eur J Clin Invest 1993; 23: 585-588.
179. Tunbridge FKE, Millar J, Schofield PJ, Spencer JA, Young G, Home PD. Diabetes care in general practice: an approach to audit of process and outcome. Br J Gen Pract 1993; 43: 291-295.
180. Wilson AE, Home PD for the Diabetic Audit Working Group of the Research Unit of the Royal College of Physicians and British Diabetic Association. A dataset to allow exchange of information for monitoring continuing diabetes care. Diabetic Med 1993; 10: 378-390
181. Piwernetz K, Home PD, Snorgaerd O, Antsiferov K, Staehr-Johansen K, Krans M for the DiabCare Monitoring Group of the St Vincent Declaration Steering Group. Monitoring the targets of the St Vincent Declaration and the implementation of Quality Management in diabetes care: the DiabCare initiative. Diabetic Med 1993; 10: 371-377.
182. Flack JR, Home PD. An approach to the use of the DOIT Study Group Guidelines for supporting the optimal implementation of information systems in diabetes care. Diabetic Med 1993; 10: 568-573.
183. Home PD. An adequate standard of care for diabetes. J Med Defence Union 1993; 9: 60-62.
Non-peer reviewed journals / books 1993
184. Home PD. Implementation of the St Vincent Declaration in the United Kingdom. G Ital Diabetologia 1993; 13 (Suppl): 89-91.
185. Home P D. Database and diabetes: Dogsbodies or devils (Editorial). Diabetic Med 1993; 10: 303-304.
186. Diabetes Services Advisory Committee. Recommendations for the management of diabetes in primary care. London: British Diabetic Association, 1993.
187. Thow JC, Home PD. Nocturnal hypoglycaemia. In: Frier BM, Fisher BM (ed). Hypoglycaemia and diabetes. London: Edward Arnold, 1993, 199-211.
188. Home PD. How should we measure the quality of diabetes care? Hospital Update 1993; 44 (therapeutics review suppl): 11-12.
Book edited - 1993
189. Marshall SM, Home PD (ed). Diabetes Annual 7. Amsterdam: Elsevier, 1993.
Peer reviewed journals 1994
191. Alexander W, Bradshaw C, Gadsby R, Home PD, Kopelman P, MacKinnon M, Redmond S, Vaughan N, for the British Diabetic Association. An approach to manageable datasets in diabetes care. Diabetic Med 1994; 11: 806-810.
192. Home PD. Diagnosing the undiagnosed with diabetes [editorial]. Br Med J 1994; 308: 611-612
Non-peer reviewed journals / books 1994
191. Robertson DA, Home PD. Problems and pitfalls of sulphonylurea therapy in older patients. Drugs Aging 1994; In press.
192. Home PD. Advances in the Organization and Implementation of Diabetes Care. In, Marshall SM, Home PD (ed), Diabetes Annual 8. Amsterdam, Elsevier, 1994, In press.
193. Home PD. A Critique of the DCCT: Implications for Europe. IDF Bulletin 1994; In press.
194. Home PD, Kruszynska YT, Tunbridge FKE. Insulin therapy, metabolic control and muscle enzymes in people with type 2 diabetes (NIDDM). In, Sakamoto N, Alberti KGMM, Hotta N (ed), Pathogenesis and treatment of NIDDM and its related problems. Amsterdam: Excerpta Medica, 1994, 125-134.
195. Clinical Standards Advisory Group. Standards of clinical care for people with diabetes. London: HMSO, 1994.
Book edited - 1994
196. Marshall SM, Home PD (ed). Diabetes Annual 8. Amsterdam: Elsevier, 1994.
Peer reviewed journals 1995
197. Kruszynska YT, Harry DS, Mohamed-Ali V, Home PD, Yudkin JS, McIntyre N. The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients. Metabolism 1995; 44: 254-260.
198. Home PD. Contributions respectives de la technique d'injection de l'insuline et de son absorption par voie sous-cutanée dans l'étiopathogènie des diabète dits instable. J Ann Diabetol Hotel-Dieu 1995; 243-255.
199. Home PD. Targets for glycated haemoglobin. Glycated haemoglobin targets are attainable [letter]. Br Med J 1995; 311:189.
200. Home P. A world of diabetes: all our problem [editorial]. Diabetic Med 1995; 12: 289-290.
201. Vaughan NJ, Home PD, for the Diabetes Audit Working Group of the Research Unit of the Royal College of Physicians and British Diabetic Association. The UK Diabetes Dataset: a standard for information exchange. Diabetic Med 1995; 12: 717-722.
202. Busch-Sorensen M, Elphick AJ, Home PD, Thorsteinsson B. Diabetes care: a guideline to the facilities needed to support internationally endorsed standards. Diabetic Med 1995; 12: 833-838.
203. International Diabetes Federation (Europe) and World Health Organization (Europe). The Acropolis Affirmation: diabetes care - St Vincent in progress. Diabetic Med 1995; 12: 636-636.
204. Home PD. Pharmacoeconomics of diabetes surveillance and detection programmes. Pharmacoeconomics 1995; 8 (suppl 1): 72-79.
205. Home PD. Economics of diabetes care must move forward [commentary]. Br Med J 1995; 311: 1599.
206. Piwernetz K, Home PD, Staehr Johansen K, Kleinebreil L, Vermeij D, Storms GEMG, Gallego MR, Massi-Benedetti M, Cowley C. DiabCare quality network in Europe telematics project within the St Vincent declaration: consensus meeting. Diabet Nutrit Metabol 1995; 8: 243-249.
Non-peer reviewed journals 1995
207. DiabCare Working Group of the St Vincent Declaration Steering Committee. Monitoring instruments for improving the quality of diabetes care. G Ital Diabetologia 1995; 15: 49-61.
208. World Health Organization. Implementation in practice. In King H, Gruber W, Lander T (ed), Implementing national diabetes programmes. Geneva: World Health Organization, 1995, 33-56.
Books edited 1995
209. Marshall SM, Home PD, Rizza RA (ed). The Diabetes Annual 9. Amsterdam: Elsevier, 1996.
Peer reviewed journals 1996
210. Home P, Day J, Elphick T. Diabetes on the Old Silk Toad [editorial]. Diabetic Med 1996; 13: 207-208.
211. Buxton C, Gibby O, Hall M, Home PD, MacKinnon M, Murphy M, et al. Diabetes information systems: a key to improving the quality of diabetes care. Diabetic Med 1996; 13 (suppl 4): S122-S128.
212. Tooke J, Baker R, Burden M, Clark A, Dornan T, Gower J, Home P, Murphy M, Toy J. Report of the research and development group. Diabetic Med 1996; 13 (suppl 4): S77-89.
213. Viberti, G-C, Marshall S, Beech R, Brown V, Derben P, Higson N, Home P, Keen H, Plant M, Walls J. Report on renal disease in diabetes. Diabetic Med 1996; 13 (suppl 4): S6-12.
214. Home PD, Hallett L. Learning from St Vincent: Diabetes action programme paves the way for better health care. IDF Bull 1996; 41 (2): 6-9.
215. Bergrem H, Kalo I, Babic D, Home P, Staehr Johansen K. Diabetes care in Europe: the St Vincent declaration coming of age? Diabet Nutrit Metabol 1997: In press.
216. Rutter M, Home PD, Alberti KGMMA. Fiveyear follow-up of cardiovascular risk factors in people with newly diagnosed Type II diabetes. Diabet Nutrit Metabol 1996; 9: 299-305.
Non-peer reviewed journals / chapters 1996
217. Wilson A, Wilbourne J, Home PD. Hospital audit of diabetes care. Diabetic Nursing 1996; 24: 12-16.
218. Home PD. the mission of St Vincent: quality in European diabetes care [editorial]. Practical Diabetes Internat 1996; 13: 40.
219. Home PD. The nature and use of registers in diabetes care. In, Dawson A (ed) Chronic Disease Management Registers. London: HMSO, 1996, 80-89.
Books/supplements edited 1996
220. Marshall SM, Home PD, Rizza RA (ed). The Diabetes Annual 10. Amsterdam: Elsevier, 1996.
221. Home PD, Hallett L (ed). Special topic: Learning from St Vincent. IDF Bull 1996; 41 (2).
Peer reviewed journals 1997
222. Home PD. Intensive Insulin Therapy in Clinical Practice. Diabetologia 1997; 40 (suppl 2): S83-S87.
223. Vaughan NJA, Jakenfelds J, Pinto FJ, Home PD. Diabetes:- the challenge for the next century. IDF Bull 1997 (1); 24-31.
224. European Arterial Risk Policy Group. Managing arterial risk in Type 2 (non-insulin-dependent) diabetes. Diabet Med 1997: 14: 611-621.
225. Canavan JP, Flecknell PA, New JP, Alberti KGMM, Home PD. The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM. Diabetologia 1997; 40: 1125-1134
226. Home PD. Insulin resistance is not central to the burden of diabetes. Diabet Metabol Rev 1997; 13: 87-92.
227. Home PD The St. Vincent Declaration Initiative to improve conditions for people with diabetes in Europe. Diabetologia 1997; 40: B14-B15.
228. Johansen KS, Home PD, for the St Vincent Executive. Improving health of people with diabetes: The ''end of the beginning'' Diabet Nutrit Metabol 1997; 10: 126-163
Non-peer reviewed journals / books 1997
229. Home PD. Clinical management systems: focus on the patient. In, Home PD (ed). Diabetes the Challenge. Zeist: Medical Forum, 1997, 47-52.
230. Home PD. Insulin therapy. In: Alberti KGMM, De Fronzo RA, Zimmet P, Keen H, (ed), International textbook of diabetes mellitus, 2nd edition. Chichester: John Wiley, 1997, 899-928.
231. Keen H, Home PD. Organization of care: Europe and the St Vincent declaration initiative. . In: Alberti KGMM, De Fronzo RA, Zimmet P, Keen H, (ed), International textbook of diabetes mellitus, 2nd edition. Chichester: John Wiley, 1997, 1709-1718.
232. European Hypertension in Diabetes Working Group. Hypertension in people with Type 2 (non-insulin-dependent) diabetes. Brussels: International Diabetes Federation (Europe), 1997.
Books edited 1997
233. Home PD (ed). Diabetes the Challenge. Zeist: Medical Forum, 1997.
Peer reviewed journals 1998
234. Ahmed ABE, Home PD. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Diabetes Care 1998; 21: 32-37.
235. Ahmed ABE, Mallias J, Home PD. Optimization of evening insulin dose in patients using the short-acting insulin analogue lispro. Diabetes Care 1998; 21: 1162-1166.
236. Johansen KS, Home PD, Berger M, Massi Benedetti M, Bergrem H, Rink HV. Improving the health of people with diabetes: the 'end of the beginning'. Diabet Nutrit Metabol 1977; 10 (suppl 3): 1-37
237. Ahmed ABE, Home PD. Opimal provision of daytime NPH insulin in patients using the insulin analog lispro. Diabetes Care 1998; 21: 1707-1713
238. Home PD, Lindholm A, Hylleberg B, Round P. Improved glycemic control with insulin aspart. Diabetes Care 1998; 21: 1904-1909
239. European Diabetes Policy Group, International Diabetes Federation, European Region. A desktop guide to type 1 (insulin-dependent) diabetes mellitus. Exp Clin Endocrinol Diabet 1998; 106: 240-269. Also as booklet, Brussels: International Diabetes Federation, 1998, 1-36.
Non-peer reviewed journals / books 1998
240. Home PD. Cost effective management of Type 1 diabetes. The fundholding and commissioning guide, volume II. London: Medical Information Systems, 1998, 145-147.
241. Home PD, Ahmed ABE. Insulin therapy. In, Marshall SM, Home PD, Rizza RA (ed), The Diabetes Annual 11. Amsterdam, Elsevier, 1998, 213-230.
242. Home P, Lauritzen T (ed). Optimising the use of ACE inhibitors in diabetes care. Practical Diabetes 1998; 15(8): S1-S5.
243. Home PD. Insulin therapy in Type 1 diabetes. In, Barnett A (ed), The insulin treatment of diabetes; a practical guide. London: Emap healthcare, 1998, 13-17.
244. Home PD, Keen H. Making Progress with Diabetes Care: a Story from the UK. IDF Bulletin 1998; 43: 8-12
Books edited 1998
245. Marshall SM, Home PD, Rizza RA (ed). The Diabetes Annual 11. Amsterdam: Elsevier, 1998.
Peer reviewed journals 1999
246. Home PD, Barriocanal L, Lindholm A. Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers. Eur J Clin Pharm 1999; 55: 199-203
247. Home PD. Rapid-acting insulin secretagogues: a clinical need? Exp Clin Endocrinol Diabet 1999; 107: S115-S119
248. European Diabetes Policy Group, International Diabetes Federation, European Region. A desktop guide to Type 1 (insulin-dependent) diabetes mellitus. Diabetic Med 1999; 16: 253-266
249. European Diabetes Policy Group, International Diabetes Federation, European Region. A desktop guide to Type 2 diabetes mellitus.
a. Diabetic Med 1999; 16: 716-730.
b. Brussels: International Diabetes Federation, 1999.
c. Medycyna Praktyczna 1999; 10 (suppl 104).
(also versions in Turkish, Georgian, Russian, Italian, German, Uzbek, Latvian, and others)
250. Home P. Is prandial glucose regulation important in Type 2 diabetes? JAMA SE Asia 1999; 15 (suppl 1): 7
251. Home P. The St Vincent Declaration Initiative. JAMA SE Asia 1999; 15 (suppl 1): 39
Non-peer reviewed journals / books 1999
252. Home PD. Insulin glargine: the first clinically useful extended-acting insulin in half a century? Exp Opin Invest Drugs 1999; 8: 307-314.
253. Home P. Insulin aspart. Drugs 1999; 57: 766-767
254. Home PD, Coles J, Goldacre M, Mason A, Wilkinson E (Ed). Health outcome indicators: diabetes. Report of a working group to the Department of Health. Oxford: National Centre for Health Outcomes Development, 1999.
255. St Vincent Declaration Working Group. Implementation of national diabetes programmes. Copenhagen: World Health Organization, 1999
256. Home PD, Schatz H. Repaglinide: a new dimension in the management of Type 2 diabetes. Exp Clin Endocrinol Diabet 1999; 107 (suppl 4): S115-S148.
257. Home PD. Management of Type 2 diabetes into the next millennium: practical applications within Europe. Diabet Obesity Metabol 1999; 1 (suppl 2).
Books edited 1999
258. Marshall SM, Home PD, Rizza RA. Diabetes Annual / 12. Amsterdam: Elsevier, 1999.
Peer reviewed journals 2000
259. Home PD, Lindholm A, Riis A, for the European Insulin Aspart Study Group. Insulin aspart versus human insulin in the management of long-term blood glucose control in Type 1 diabetes: a randomized controlled trial. Diabet Med 2000; 17: 762-770.
260. Home PD. Rapid-acting insulin analogues: when randomized clinical trial results do not help. Diabet Med 2000; 17 (suppl 2): 6-8.
Non-peer reviewed journals 1999
261. Gallagher A, Home PD. Humalog Mix25: first insulin analogue mixture. Prescriber. 2000; 11(6): 107-110.
262. Home PD. Arterial risk management in Type 2 diabetes. Post Grad Med 2000; 14: 349-367.
263. Home PD. Insulin therapy: new concepts and new tools. Bangalore: Novo Nordisk, 2000.
264. Hutchinson A, McIntosh A, Feder G, Home PD, Young R, for the Foot Care Working Group. Clinical guidelines for Type 2 diabetes. Prevention and management of foot problems. London: Royal College of General Practitioners, 2000.
265. Home PD. Postprandial hyperglycaemia: mechanisms and importance. Diabet Obesity Metabol 2000; 2 (suppl 1) S7-S11
Peer reviewed journals 2001
266. Ramtoola S, Home PD, Damry H, Husnoo A, Ab-Kion S. Gestational impaired glucose tolerance does not increase perinatal mortality in a developing country: cohort study. BMJ 2001; 322: 1025-1026
267. Ahmed ABE, Badgandi M, Home PD. Interval between insulin injection and meal in relation to glycated haemoglobin. Pract Diabet Int 2001: 18: 51-56
268. Home PD. Therapeutic targets in the management of Type 1 diabetes. Diabet Metab Res Rev 2001; 17 (suppl 2): S1-S9.
269. Ashwell SG, Home PD. Insulin glargine: the first clinically useful extended-action insulin analogue. Exp Opin Pharmacother 2001; 2: 1891-1902.
Non-peer reviewed journals/books 2001
270. Home PD. A brief history of insulin therapy. In Barnett AH (ed), Insulin made easy. Medical Education Partnership, 2001, 7-14.
271 Home PD. Organisation of diabetes care. In, Wass JAH, Shalet SM (ed), Oxford Textbook of Endocrinology. Oxford: Oxford University Press, 2001, In press.
272 A McIntosh, A Hutchinson, PD Home, Brown F, Bruce A, Damerell A, Davis R, Field R, Frost , Marshall S, Roddick J, Tesfaye S, Withers H, Suckling R, Smith S, Griffin S, Kaltenthaler E, Peters J, Feder G. Clinical guidelines and evidence review for Type 2 diabetes: management of blood glucose. Sheffield: ScHARR, University of Sheffield 2001. http://www.nice.org.uk
Peer reviewed journals 2002
273. Boehm BO, Home PD, Behrend C, Kamp NM, Lindholm A. Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients. Diabet Med 2002; 19: 393-9.
274. Lindholm A, Jensen LB, Home PD, Raskin P, Boehm BO, Rastam J. Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diabetes Care 2002; 25: 876-82.
275. Home P. Chacra A. Chan J. Emslie-Smith A. Sorensen L. Van Crombrugge P. Boulton A. Davidson J. Dornan T. Heine R. Jimenez J. Kangas T. Kawamori R. Landgraf R. Massi-Benedetti M. Mogensen CE. Christiansen JS. Skyler J. Sorensen L. Uccioli L. Van Crombrugge P. Considerations on blood glucose management in type 2 diabetes mellitus. Diabet Metabol Res Rev 2002; 18: 273-285.
276. Working Party of the International Diabetes Federation (European Region) (chair Home PD). Hypertension in people with Type 2 diabetes: knowledge-based diabetes-specific guidelines. Diabet Med 2003; 20: 972-987.
277. Home PD, Ashwell SG. An overview of insulin glargine. Diabet Metab Res Rev 2002: 18 (suppl 3): S75-S63.
287 Home PD. Therapeutic targets in the management of type 1 diabetes. Diabet Metabol Res Rev 2002: 18 (suppl 1); S7-S13.
Non-peer reviewed journals/books 2002
279. Home PD. Thiazolidenediones: increasing insulin sensitivity. In, Amiel S, Horizons in Medicine, volume 13. London: Royal College of Physicians, 2002, 185-194.
280. McIntosh A Hutchinson A Marshall S Barnes D Brown V Hopper S Nicholls A Peters J, Viberti GC, Walker J, Feder G, Home PD (2002) Clinical Guidelines and Evidence Review for Type 2 Diabetes. Renal Disease: Prevention and Early Management. Sheffield: ScHARR, University of Sheffield, 2002. (Also www.nice.org.uk)
281. Marshall SM, Home PD, Manley SE, Barth JH, John WG. Standardization of glycated haemoglobin. Diabet Med 2002; 19: 429, and Ann Clin Biochem 2002; 39: 78-9.
282. Home PD. Editorials:
a Vociferous about diabetes. Diabetes Voice 2002; 47 (1): 3.
b The changing face of guidelines. Diabetes Voice 2002; 47 (2): 1.
c The life-cycle of a woman's diabetes. Diabetes Voice 2002; 47 (special issue: Women and diabetes): 3.
d Learning diabetes. Diabetes Voice 2002; 47 (3): 3
e Global danger from pharmaceutical regulation. Diabetes Voice 2002; 47 (4): 3
283. Home PD. Expensive new drugs: NICE , or not so nice? Diabetes Voice 2002; 47 (2): 33-36.
284. Home PD. The drug dilemma. Diabetes Voice 2002; 47 (special issue Women and diabetes): 14-15.
Peer reviewed journals 2003
285. De Vries JH, Lindholm A, Jacobsen JL, Heine RJ, Home PD. A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes. Diabet Med 2003; 20: 312-318.
286. Home P. The challenge of poorly controlled diabetes mellitus. Diabet Metabol 2003; 101-109.
287. Home PD. Boulton AJM. Jimenez J. Landgraf R. Osterbrink B. Christiansen JS. Issues relating to the early or earlier use of insulin in type 2 diabetes. Pract Diabet Internat 2003; 20 (2): 63-71.
Non-peer reviewed journals/books 2003
288. McIntosh A, Peters J, Young R, Hutchinson A, Chiverton R, Clarkson S, Foster A, Gadsby R, O’Connor M, Rayman G, Feder G, Home PD. Prevention and management of foot problems in Type 2 diabetes: Clinical guidelines and evidence. Sheffield: University of Sheffield, 2003. (Also summarized as NICE guideline 2004, www.nice.org.uk)
289. Home PD. PPAR-? modulators: their role in diabetes care. In Raz I, Skyler J, Shafir E (ed), Diabetes: from research to diagnosis and treatment. London: Martin Dunitz, 2003, 347-362
290. Home PD. Diabetes Voice editorials:
a A diabetes presence. Diabetes Voice 2003; 48 (1): 3
b Where next for IDF? Diabetes Voice 2003; 48 (2): 3
c Prevention comes of age. Diabetes Voice 2003; 48 (prevention): 3
d It’s all kidneys. Diabetes Voice 2003; 48 (kidneys): 3
e Diabetes beyond health care. Diabetes Voice 2003; 48 (3): 3
f The very centre of care. Diabetes Voice 2003; 48 (4): 3
291. Home PD. Going down: lipids and all that cholesterol. Diabetes Voice 2003;; 48 (prevention); 47-48.
292. Home PD. A guide to guide diabetes guideline development. Diabetes Voice 2003; 48 (3):18-20.
Peer reviewed journals 2004
293. Home P, Bartley P, Russell-Jones D, Hanaire-Broutin H, Heeg JE, Abrams P, Landin-Olsson M, Hylleberg B, Lang H, Draeger E. Insulin detemir offers improved glycemic control compared with NPH Insulin in people with Type 1 Diabetes. Diabetes Care 2004; 27: 1081-1087.
294. Boehm BO, Vaz JA, Brondsted L, Home PD. Long term efficacy and safety of biphasic insulin aspart in people with Type 2 diabetes. Eur J Int Med 2004; 15: 496-502.
295. Consoli A, Gomis R, Halimi S, Home PD, Mehnert H, Strojek K, Van Gaal LF. Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: An evidence-based strategy to reduce the burden of late-developing diabetes complications. Diabet Metab 2004; 30 509-516.
296. PD Home, J-C Mbanya, E Horton . Standardization of glycated haemoglobin. BMJ 2004; 329, 1196-1197.
Non-peer reviewed journals/books 2004
297. The National Collaborating Centre for Chronic Conditions. Type 1 diabetes in adults (Home PD, clinical lead). London: Royal College of Physicians, 2004
298. Smith SC Jr, Jackson R, Pearson TA, Fuster V, Yusuf S, Faergeman O, Wood DA, Alderman M, Horgan J, Home P, Hunn M, Grundy SM. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 2004; 109: 3112-21.
299. International Diabetes Federation Clinical Guidelines Task Force (Home PD, chair). Guide for guidelines: A guide for clinical guidelines development. Brussels: International Diabetes Federation, 2004. (www.idf.org)
300. Home PD. Diabetes Voice editorials:
a Not the blank slate. Diabetes Voice 2004; 49 (1): 3
b Deaths from diabetes. Diabetes Voice 2004; 49 (2): 3
c It’s all about the people. Diabetes Voice 2004; 49 (special issue: People with diabetes): 3
d Diabetes Care in need. Diabetes Voice 2004; 49 (3): 3
e Understanding the evidence. Diabetes Voice 2004; 49 (special issue: Eating): 3
301 Home PD. Glucose: sweetness and toxin. Diabetes Voice 2004: 49 (special issue: Eating): 5-7.
Peer reviewed journals 2005
302. A Gallagher, PD Home. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes. Diabet Res Clin Pract 2005; 67: 196-203.
303. Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Dargie H, Komajda M, Gubb J, Biswas M, Jones NP. Rosiglitazone evaluated for cardiac outcomes and regulation of glycaemia in diabetes (RECORD): study design and protocol. Diabetologia 2005; 48: 1726-35. http://dx.doi.org/10.1007/s00125-005-1869-1
304. A Wilkinson, J Davidson, F Dotta, P Home, P Keown, B Kiberd, A Jardine, N Levitt, P Marchetti, M Markell, S Naicker, P O'Connell, M Schnitzler, E Standl, J-V Torregrosa, K Uchida, H Valantine, F Villamil, F Vincenti, M Wissing. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005; 19: 291-298.
305. Home PD, R Rosskamp, J Forjanic-Klapproth, A Dressler, for the European Insulin Glargine Study Group. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes. Diabetes Metab Res Rev 2005: 21; 545-553.
Non-peer reviewed journals/books 2005
306. Home P. Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin 2005; 21: 989-996.
307. International Diabetes Federation Task Force on Clinical Guidelines [Home PD, Chair]. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005. www.idf.org
308. Diabetes UK. Recommendations for the provision of services in primary health care for people with diabetes. London: Diabetes UK, 2005.
309. Home PD, Home EM. International textbook of diabetes mellitus. [Book review.] Diabet Med. 2005; 22: 1460-1460.
310. R Thomas, PD Home. Insulin therapy for people with Type 1 diabetes. Prescriber 2005; 16 (6): 48-58.
Published or confirmed in press 2006 (to January)
311. SG Ashwell, J Gebbie, PD Home. Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times. Diabet Med 2005: In press. 305. A Bagust, M Evans, S Beale, PD Home, AS Perry, M Stewart. A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies. Drugs 2005; In press.
312. Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, Shutler DA, Stephens WA, Home PD. Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes. Diabet Med 2005; 22: In press.
313. Home PD, Hallgren P, Usadel KH, Sane T, Faber J, Grill V, Friberg HH. Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes. Diabet Res Clin Pract 2005: In press. E-published 16 Jul.
314. Hanney SR, Home PD, Frame I, Grant P, Green P, Buxton MJ. Identifying the impact of diabetes research. Diabet Med 2005: 22: In press. doi:10.1111/j.1464-5491.2005.01753.x
315. Home PD, Kurtzhals P. Insulin detemir: from concept to clinical practice. Expert Opinion on Pharmacotherapy 2006; [accepted December 2005]
(last update December 2005)